Vorapaxar Sulfate Patent Expiration
Vorapaxar Sulfate is Used for preventing heart attacks and strokes in patients with a history of heart attack or peripheral arterial disease. It was first introduced by Key Therapeutics Llc
Vorapaxar Sulfate Patents
Given below is the list of patents protecting Vorapaxar Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zontivity | US7304078 | Thrombin receptor antagonists | Dec 23, 2027 | Key Therap |
| Zontivity | US7713999 | Thrombin receptor antagonists |
May 30, 2024
(Expired) | Key Therap |
| Zontivity | US7235567 | Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
Jun 13, 2021
(Expired) | Key Therap |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Vorapaxar Sulfate's patents.
Latest Legal Activities on Vorapaxar Sulfate's Patents
Given below is the list recent legal activities going on the following patents of Vorapaxar Sulfate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Court Processing Terminated | 02 Apr, 2024 | US7304078 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 29 Sep, 2021 | US7713999 |
| Email Notification Critical | 09 Nov, 2020 | US7713999 |
| Change in Power of Attorney (May Include Associate POA) Critical | 09 Nov, 2020 | US7713999 |
| Correspondence Address Change Critical | 05 Nov, 2020 | US7713999 |
| Change in Power of Attorney (May Include Associate POA) Critical | 03 Nov, 2020 | US7235567 |
| Email Notification Critical | 03 Nov, 2020 | US7235567 |
| Correspondence Address Change Critical | 01 Nov, 2020 | US7235567 |
| Patent Term Extension Certificate Critical | 03 Sep, 2020 | US7304078 |
| Notice of Final Determination -Eligible | 29 Jun, 2020 | US7304078 |
Vorapaxar Sulfate's Family Patents
